Elise C Kohn Selected Research

Proteome

11/2011	Proteomics and biomarkers in clinical trials for drug development.
11/2007	Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines.
9/2003	Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elise C Kohn Research Topics

Disease

68	Neoplasms (Cancer) 11/2021 - 01/2002
56	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
11	Ovarian Epithelial Carcinoma 02/2016 - 01/2002
10	Carcinoma (Carcinomatosis) 11/2020 - 09/2003
5	Neutropenia 04/2019 - 10/2009
5	Hypertension (High Blood Pressure) 12/2018 - 02/2009
4	Fatigue 07/2017 - 07/2007
4	Leukemia 03/2012 - 11/2006
4	Prostatic Neoplasms (Prostate Cancer) 07/2010 - 10/2002
4	Colonic Neoplasms (Colon Cancer) 07/2008 - 03/2005
3	Disease Progression 01/2020 - 05/2009
3	Thrombocytopenia (Thrombopenia) 04/2019 - 03/2017
3	Carcinogenesis 01/2017 - 09/2003
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011 - 11/2007
3	Neoplasm Metastasis (Metastasis) 08/2009 - 05/2004
2	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 01/2018
2	Adenocarcinoma 01/2021 - 11/2007
2	Triple Negative Breast Neoplasms 01/2019 - 10/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2016
2	Melanoma (Melanoma, Malignant) 11/2014 - 10/2003
2	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 03/2005
2	Breast Neoplasms (Breast Cancer) 08/2009 - 09/2006
2	Xeroderma Pigmentosum (Kaposi's Disease) 01/2008 - 06/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2006 - 09/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 03/2005 - 09/2004
1	Genomic Instability 10/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Peritoneal Diseases 01/2020
1	Sepsis (Septicemia) 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2019
1	Infections 04/2019

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 02/2016 - 01/2002
25	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2002
16	Pharmaceutical PreparationsIBA 01/2020 - 02/2005
14	olaparibIBA 01/2022 - 06/2014
11	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020 - 01/2014
10	carboxyamido-triazole (carboxyamidotriazole)IBA 10/2009 - 03/2003
9	PlatinumIBA 01/2022 - 10/2014
7	cediranib (AZD2171)IBA 01/2022 - 10/2014
7	Bevacizumab (Avastin)FDA Link 10/2020 - 08/2008
6	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 08/2008
6	Phosphotransferases (Kinase)IBA 10/2020 - 04/2007
6	DNA (Deoxyribonucleic Acid)IBA 09/2019 - 09/2003
6	Carboplatin (JM8)FDA LinkGeneric 04/2019 - 07/2011
6	Paclitaxel (Taxol)FDA LinkGeneric 09/2011 - 11/2007
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2003
5	ProgranulinsIBA 01/2011 - 01/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2003
4	Asparaginase (Elspar)FDA Link 05/2013 - 11/2006
4	Secretory Leukocyte Peptidase InhibitorIBA 09/2011 - 03/2008
4	GranulinsIBA 10/2005 - 01/2003
3	Messenger RNA (mRNA)IBA 01/2020 - 10/2008
3	Biological ProductsIBA 01/2019 - 02/2006
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016 - 01/2014
3	ProteomeIBA 11/2011 - 09/2003
3	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 07/2007
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2010 - 11/2007
3	Cisplatin (Platino)FDA LinkGeneric 03/2010 - 11/2007
3	RNA (Ribonucleic Acid)IBA 10/2008 - 01/2002
2	Gemcitabine FDA Link 01/2021 - 01/2020
2	berzosertibIBA 01/2021 - 01/2020
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2019 - 01/2019
2	durvalumabIBA 01/2019 - 07/2017
2	Drug CombinationsIBA 01/2019 - 01/2014
2	Caspase 3 (Caspase-3)IBA 02/2016 - 10/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 01/2015
2	Interleukin-8 (Interleukin 8)IBA 01/2015 - 10/2003
2	EnzymesIBA 02/2013 - 11/2006
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2011 - 03/2009
2	Transcription Factors (Transcription Factor)IBA 07/2010 - 05/2010
2	NF-kappa B (NF-kB)IBA 07/2010 - 05/2010
2	CalciumIBA 10/2009 - 03/2005
2	Proline (L-Proline)FDA Link 08/2009 - 09/2006
2	Peptide Hydrolases (Proteases)FDA Link 03/2009 - 03/2008
2	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 10/2008 - 11/2006
2	ErbB Receptors (EGF Receptor)IBA 07/2007 - 04/2007
2	lysophosphatidic acidIBA 10/2005 - 01/2002
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2021
1	AntigensIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	entinostat (MS 275)IBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 09/2019
1	CyclinsIBA 09/2019
1	Investigational DrugsIBA 09/2019
1	Angiogenesis InhibitorsIBA 09/2019
1	human ERBB2 proteinIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	RadiopharmaceuticalsIBA 01/2019
1	DeoxyribonucleotidesIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019

Therapy/Procedure

38	Therapeutics 01/2022 - 08/2002
10	Drug Therapy (Chemotherapy) 01/2022 - 05/2004
3	Radiotherapy 11/2020 - 01/2019
3	Lasers (Laser) 09/2005 - 01/2002
1	Palliative Care (Palliative Therapy) 01/2021
1	Cytoreduction Surgical Procedures 01/2019